Treatment of eosinophilic esophagitis with mometasone furoate aerosol: a randomised, placebo-controlled phase II study for evaluation of treatment effect on group level including symptom questionnaires.

Trial Profile

Treatment of eosinophilic esophagitis with mometasone furoate aerosol: a randomised, placebo-controlled phase II study for evaluation of treatment effect on group level including symptom questionnaires.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 15 May 2017

At a glance

  • Drugs Mometasone (Primary)
  • Indications Eosinophilic oesophagitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2014 New source identified and integrated (ClinicalTrials.gov NCT02113267)
    • 28 Jan 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top